Login / Signup

Capturing the young child's reports of cancer treatment tolerability: Does our practice reflect an assumption that they cannot report?

Bryce B ReeveAlexy HernandezDavid R FreyerLauri A LinderLeanne EmbryAllison Barz LeahyJustin N BakerJennifer W MackMolly McFatrichDebra M HenkeCatriona MowbrayShana S JacobsScott H MaurerStuart H GoldPamela S Hinds
Published in: Pediatric blood & cancer (2022)
Keyphrases
  • primary care
  • open label
  • mental health
  • healthcare
  • middle aged
  • adverse drug
  • quality improvement
  • double blind
  • randomized controlled trial
  • emergency department
  • electronic health record